Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4623)
All Articles published online
|
Jun 14, 2005 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang YS, Yuan FJ, Jia GF, Zhang JF, Hu LY, Huang L, Wang J, Dai ZQ. CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R. World J Gastroenterol 2005; 11(22): 3339-3345 [PMID: 15948236 DOI: 10.3748/wjg.v11.i22.3339] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i22/3339.htm |
| Number | Citing Articles |
| 1 |
Qiu-Zhong Pan, Yan Tang, Qi-Jing Wang, Yong-Qiang Li, Li Zhang, Xiao-Dong Li, Jing-Jing Zhao, De-Sheng Weng, Qing Liu, Li-Xi Huang, Jia He, Shi-Ping Chen, Miao-La Ke, Yi-Xin Zeng, Jian-Chuan Xia. Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer. OncoImmunology 2015; 4(9): e1038017 doi: 10.1080/2162402X.2015.1038017
|
| 2 |
Jian Wang, Min He, Weijin Shi, Huifang Sha, Jiuxian Feng, Shujun Wang, Ying Wang. Inducible Costimulator (ICOS) Enhances the Cytolytic Activity of Cytokine-Induced Killer Cells Against Gallbladder CancerIn VitroandIn Vivo. Cancer Investigation 2009; 27(3): 244 doi: 10.1080/07357900802239124
|
| 3 |
Sharmilan Thanendrarajan, Michael Nowak, Hinrich Abken, Ingo G.H. Schmidt-Wolf. Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: More than one plus one?. Leukemia Research 2011; 35(9): 1136 doi: 10.1016/j.leukres.2011.05.005
|
| 4 |
FangJun Yuan, Wenbo Zhou, Jifa Zhang, Zhiyun Zhang, Can Zou, Ling Huang, YouShun Zhang, Zongqing Dai. Anticancer drugs are synergistic with freezing in induction of apoptosis in HCC cells. Cryobiology 2008; 57(1): 60 doi: 10.1016/j.cryobiol.2008.06.001
|
| 5 |
Li Lin, Yonggao Mu, Zhongping Chen. Preliminary study of local immunotherapy with autologous cytokine-induced killer cells for glioma patients. Chinese Journal of Clinical Oncology 2008; 5(4): 268 doi: 10.1007/s11805-008-0268-z
|
| 6 |
Chemotherapy in combination with cytokine-induced killer cell transfusion: An effective therapeutic option for patients with extensive stage small cell lung cancer. International Immunopharmacology 2017; 46: 170 doi: 10.1016/j.intimp.2016.12.005
|
| 7 |
Gbemisola Lawal, Yao Xiao, Amir A. Rahnemai-Azar, Diamantis I. Tsilimigras, Ming Kuang, Anargyros Bakopoulos, Timothy M. Pawlik. The Immunology of Hepatocellular Carcinoma. Vaccines 2021; 9(10): 1184 doi: 10.3390/vaccines9101184
|
| 8 |
Dengqiang Wu, Yujie Li. Application of adoptive cell therapy in hepatocellular carcinoma. Immunology 2023; 170(4): 453 doi: 10.1111/imm.13677
|
| 9 |
Ji Sung Kim, Yong Guk Kim, Minji Pyo, Hong Kyung Lee, Jin Tae Hong, Youngsoo Kim, Sang-Bae Han. Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells. Immune Network 2015; 15(2): 58 doi: 10.4110/in.2015.15.2.58
|
| 10 |
Hwan Mook Kim, Jaeseung Lim, Yeo Dae Yoon, Ji Mi Ahn, Jong Soon Kang, Kiho Lee, Song-Kyu Park, Yu Jin Jeong, Jin Mi Kim, Gyoonhee Han, Kyu-Hwan Yang, Yeon Jin Kim, Youngsoo Kim, Sang-Bae Han. Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma. International Immunopharmacology 2007; 7(13): 1793 doi: 10.1016/j.intimp.2007.08.007
|
| 11 |
Samad Muhammadnejad, Seyed Mostafa Monzavi, Monireh Torabi-Rahvar, Masoud Sotoudeh, Ahad Muhammadnejad, Sahar Tavakoli-Shiraji, Azam Ranjbar, Seyed Sajjad Aghayan, Amir Arsalan Khorsand, Kobra Moradzadeh, Ehsan Janzamin, Naser Ahmadbeigi. Efficacy of adoptively transferred allogeneic CIK cells on colorectal cancer: Augmentative antitumoral effects of GvHD. International Immunopharmacology 2023; 114: 109446 doi: 10.1016/j.intimp.2022.109446
|
| 12 |
Yong-bing CHEN, Mao-lin YAN, Jian-ping GONG, Ren-pin XIA, Li-xin LIU, Ning LI, Shi-chun LU, Jing-guang ZHANG, Dao-bing ZENG, Jian-guo XIE, Jia-yin YANG, Lü-nan YAN. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1. Chinese Medical Journal 2007; 120(8): 703 doi: 10.1097/00029330-200704020-00017
|
| 13 |
Marta Franceschetti, Alice Pievani, Gianmaria Borleri, Luca Vago, Katharina Fleischhauer, Josée Golay, Martino Introna. Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes. Experimental Hematology 2009; 37(5): 616 doi: 10.1016/j.exphem.2009.01.010
|
| 14 |
Qing-Kun Song, Jun Ren, Xin-Na Zhou, Xiao-Li Wang, Guo-Hong Song, Li-Jun Di, Jing Yu, Amy Hobeika, Michael A. Morse, Yan-Hua Yuan, Hua-Bing Yang, Herbert Kim Lyerly. The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion. Oncotarget 2015; 6(38): 41350 doi: 10.18632/oncotarget.5534
|
| 15 |
Ke Pan, Xun-Xing Guan, Yong-Qiang Li, Jing-Jing Zhao, Jian-Jun Li, Hui-Juan Qiu, De-Sheng Weng, Qi-Jing Wang, Qing Liu, Li-Xi Huang, Jia He, Shi-Ping Chen, Miao-La Ke, Yi-Xin Zeng, Jian-Chuan Xia. Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer. Clinical Cancer Research 2014; 20(11): 3003 doi: 10.1158/1078-0432.CCR-14-0082
|
| 16 |
Yuanlong Gu, Huimin Lv, Juan Zhao, Qi Li, Guannan Mu, Jiade Li, Jiazi Wuyang, Ge Lou, Ruitao Wang, Yanqiao Zhang, Xiaoyi Huang. Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC). International Immunopharmacology 2017; 50: 263 doi: 10.1016/j.intimp.2017.07.006
|
| 17 |
Ji Sung Kim, Yong Guk Kim, Hong Kyung Lee, Eun Jae Park, Boyeong Kim, Jong Soon Kang, Heesoon Lee, Youngsoo Kim, Jin Tae Hong, Sang-Bae Han. Cytokine-induced killer cells hunt individual cancer cells in droves in a mouse model. Cancer Immunology, Immunotherapy 2017; 66(2): 193 doi: 10.1007/s00262-016-1934-2
|
| 18 |
YONG ZHANG, YONGPING SONG, QUANLI GAO. Increased survival time of a patient with metastatic malignant melanoma following immunotherapy: A case report and literature review. Oncology Letters 2015; 10(2): 883 doi: 10.3892/ol.2015.3296
|
| 19 |
Shengguang Li, Fujun Peng, Yichong Ning, Peng Jiang, Jian Peng, Xiaofeng Ding, Jian Zhang, Taijiao Jiang, Shuanglin Xiang. SNHG16 as the miRNA let‐7b‐5p sponge facilitates the G2/M and epithelial‐mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma. Journal of Cellular Biochemistry 2020; 121(3): 2543 doi: 10.1002/jcb.29477
|
| 20 |
Qi Niu, Wei Wang, Yong Li, Shaowen Qin, Yu Wang, Guangyu Wan, Jingzhi Guan, Wenhua Zhu. Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies. International Immunopharmacology 2011; 11(4): 449 doi: 10.1016/j.intimp.2010.12.014
|
| 21 |
Clara E. Jäkel, Annabelle Vogt, Maria A. Gonzalez-Carmona, Ingo G. H. Schmidt-Wolf. Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors. Journal of Immunology Research 2014; 2014: 1 doi: 10.1155/2014/897214
|
| 22 |
Tobi L. Schmidt, Robert S. Negrin, Christopher H. Contag. A killer choice for cancer immunotherapy. Immunologic Research 2014; 58(2-3): 300 doi: 10.1007/s12026-014-8507-2
|
| 23 |
Yue Ma, Zan Zhang, Lei Tang, Ying-Chun Xu, Zhi-Ming Xie, Xiao-Feng Gu, Hong-Xia Wang. Cytokine-induced killer cells in the treatment of patients with solid carcinomas: a systematic review and pooled analysis. Cytotherapy 2012; 14(4): 483 doi: 10.3109/14653249.2011.649185
|
| 24 |
Xinyu Zhu, Zhiwei Li, Li Chen, Limin Li, Mi Ouyang, Hao Zhou, Kai Xiao, Ling Lin, Paul K. Chu, Chang Zhou, Chengfeng Xun, Liu Yang, Wenhuan Huang, Xiaofeng Ding. Targeting KCTD1 as a Potential Novel Therapy Ameliorates Hepatocellular Carcinoma Progression via the HIF-1α/VEGF Pathway. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4047141
|
| 25 |
Hui Li, Jin-Pu Yu, Shui Cao, Feng Wei, Peng Zhang, Xiu-Mei An, Zong-Tang Huang, Xiu-Bao Ren. CD4
+CD25
+ Regulatory T Cells Decreased the Antitumor Activity of Cytokine-Induced Killer (CIK) Cells of Lung Cancer Patients. Journal of Clinical Immunology 2007; 27(3): 317 doi: 10.1007/s10875-007-9076-0
|
| 26 |
Xiao-Dong Li, Bin Xu, Jun Wu, Mei Ji, Bei-Hua Xu, Jing-Ting Jiang, Chang-Ping Wu. Review of Chinese clinical trials on CIK cell treatment for malignancies. Clinical and Translational Oncology 2012; 14(2): 102 doi: 10.1007/s12094-012-0768-4
|
| 27 |
Yuan Yuanying, Niu Lizhi, Mu Feng, Wang Xiaohua, Zeng Jianying, Yao Fei, Jiang Feng, He Lihua, Chen Jibing, Li Jialiang, Xu Kecheng. Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer. Cryobiology 2013; 67(2): 235 doi: 10.1016/j.cryobiol.2013.08.001
|
| 28 |
Ji Sung Kim, In Sung Chung, Sang Hee Lim, Yunsoo Park, Mi Jeong Park, Ju Young Kim, Yong Guk Kim, Jin Tae Hong, Youngsoo Kim, Sang-Bae Han. Preclinical and clinical studies on cytokine-induced killer cells for the treatment of renal cell carcinoma. Archives of Pharmacal Research 2014; 37(5): 559 doi: 10.1007/s12272-014-0381-x
|
| 29 |
Lili Yang, Baozhu Ren, Hui Li, Jinpu Yu, Shui Cao, Xishan Hao, Xiubao Ren. Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients. Cancer Immunology, Immunotherapy 2013; 62(1): 65 doi: 10.1007/s00262-012-1311-8
|
| 30 |
Jinpu Yu, Xiubao Ren, Hui Li, Shui Cao, Ying Han, Tatsuji Enoki, Ikunoshin Kato, Chunyu Cao, Xishan Hao. Synergistic Effect of CH-296 and Interferon Gamma on Cytokine-Induced Killer Cells Expansion for Patients with Advanced-Stage Malignant Solid Tumors. Cancer Biotherapy and Radiopharmaceuticals 2011; 26(4): 485 doi: 10.1089/cbr.2010.0927
|
| 31 |
Yiqi Fan, Shuai He. The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer. Cancer Management and Research 2022; : 1 doi: 10.2147/CMAR.S316700
|
| 32 |
YA-FENG WANG, PATRICIA E. KUNDA, JIAN-WEI LIN, HAN WANG, XUE-MEI CHEN, QIU-LING LIU, TAO LIU. Cytokine-induced killer cells co-cultured with complete tumor antigen-loaded dendritic cells, have enhanced selective cytotoxicity on carboplatin-resistant retinoblastoma cells. Oncology Reports 2013; 29(5): 1841 doi: 10.3892/or.2013.2315
|
| 33 |
Li Zhang, Yanyan Pan. Lung Cancer - Strategies for Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.78274
|
| 34 |
Jinying Zhang, Lingjun Zhu, Haina Du, Xiang He, Yongmei Yin, Yanhong Gu, Lianke Liu, Kaihua Lu, Renhua Guo, Ping Liu, Yongqian Shu. Autologous cytokine-induced killer cell therapy in lung cancer patients: A retrospective study. Biomedicine & Pharmacotherapy 2015; 70: 248 doi: 10.1016/j.biopha.2014.12.025
|
| 35 |
Tao Lin, Chun Song, Dong-yu Chuo, Hao Zhang, Jian Zhao. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study. Tumor Biology 2016; 37(4): 4367 doi: 10.1007/s13277-015-3957-2
|
| 36 |
Xiao-Dong Li, Mei Ji, Xiao Zheng, Zhong-Hua Ning, Jun Wu, Binfeng Lu, Chang-Ping Wu, Jing-Ting Jiang. Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors. Journal of Translational Medicine 2014; 12(1) doi: 10.1186/s12967-014-0215-0
|
| 37 |
Junping Zhang, Guanghua Mao, Yaping Han, Xiaoling Yang, Huijing Feng, Linzi Jia, Ting Zhi, Yan Xiao, Libin Zhang, Jiangtao Wang, Tianliang Shi. The clinical effects of DC-CIK cells combined with chemotherapy in the treatment of advanced NSCLC. The Chinese-German Journal of Clinical Oncology 2012; 11(2): 67 doi: 10.1007/s10330-011-0929-x
|